{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:09:04Z","timestamp":1788887344512,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T00:00:00Z","timestamp":1546128000000},"content-version":"vor","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004909","name":"Universidade Federal do Rio Grande do Sul","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004909","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006303","name":"Associa\u00e7\u00e3o Fundo de Incentivo \u00e0 Pesquisa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006303","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.lfs.2017.10.038","type":"journal-article","created":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T19:17:27Z","timestamp":1509477447000},"page":"242-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Oral supplementation of melatonin protects against lupus nephritis renal injury in a pristane-induced lupus mouse model"],"prefix":"10.1016","volume":"193","author":[{"given":"Mariane","family":"dos Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Favero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bonomini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Stacchiotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi Fabrizio","family":"Rodella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Ver\u00edssimo","family":"Veronese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7515-5846","authenticated-orcid":false,"given":"Rita","family":"Rezzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2017.10.038_bb0005","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","article-title":"The frequency and outcome of lupus nephritis: results from an international inception cohort study","volume":"55","author":"Hanly","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lfs.2017.10.038_bb0010","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.autrev.2012.08.018","article-title":"Lupus nephritis: a critical review","volume":"12","author":"Borchers","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.lfs.2017.10.038_bb0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/BOR.0b013e328354c877","article-title":"Lupus nephritis. How latest insights into its pathogenesis promote novel therapies","volume":"24","author":"Kulkarni","year":"2012","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.lfs.2017.10.038_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2015.00475","article-title":"Mechanisms of kidney injury in lupus nephritis - the role of anti-dsDNA antibodies","volume":"6","author":"Yung","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2017.10.038_bb0025","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1177\/0961203311418791","article-title":"Role of reactive intermediates in the immunopathogenesis of the pristane-induced Balb\/c model of lupus","volume":"20","author":"Minhas","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.lfs.2017.10.038_bb0030","article-title":"Resveratrol possesses protective effects in a pristane-induced lupus mouse model","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2017.10.038_bb0035","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1017\/S0954422417000026","article-title":"An update on diet and nutritional factors in systemic lupus erythematosus management","volume":"30","author":"Aparicio-Soto","year":"2017","journal-title":"Nutr. Res. Rev."},{"key":"10.1016\/j.lfs.2017.10.038_bb0040","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.4049\/jimmunol.1501943","article-title":"TLR9 deficiency leads to accelerated renal disease and myeloid lineage abnormalities in pristane-induced murine lupus","volume":"197","author":"Bossaller","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2017.10.038_bb0045","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.it.2009.06.003","article-title":"Induction of autoimmunity by pristane and other naturally occurring hydrocarbons","volume":"30","author":"Reeves","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.lfs.2017.10.038_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2015.3953","article-title":"Reducing progression of experimental lupus nephritis via inhibition of the B7\/CD28 signaling pathway","volume":"12","author":"Huang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2017.10.038_bb0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.apsb.2016.07.001","article-title":"Salvianolic acid A alleviates renal injury in systemic lupus erythematosus induced by pristane in BALB\/c mice","volume":"7","author":"Lin","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.lfs.2017.10.038_bb0060","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/cei.12647","article-title":"Targeted IgA Fc receptor I (Fc\u03b1RI) therapy in the early intervention and treatment of pristane-induced lupus nephritis in mice","volume":"181","author":"Liu","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.lfs.2017.10.038_bb0065","doi-asserted-by":"crossref","first-page":"10934","DOI":"10.1073\/pnas.92.24.10934","article-title":"Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB\/c mice treated with pristane","volume":"92","author":"Satoh","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2017.10.038_bb0070","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/art.39109","article-title":"Suppression of autoimmunity and renal disease in pristane-induced lupus by myeloperoxidase","volume":"67","author":"Odobasic","year":"2015","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.lfs.2017.10.038_bb0075","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.trsl.2014.01.003","article-title":"Assessment of the translational value of mouse lupus models using clinically relevant biomarkers","volume":"163","author":"Bender","year":"2014","journal-title":"Transl. Res."},{"key":"10.1016\/j.lfs.2017.10.038_bb0080","first-page":"325","article-title":"Melatonin: exceeding expectations","volume":"29","author":"Reiter","year":"2014","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.lfs.2017.10.038_bb0085","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/jpi.12287","article-title":"Melatonin prevents kidney injury in a high salt diet-induced hypertension model by decreasing oxidative stress","volume":"60","author":"Leibowitz","year":"2016","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2017.10.038_bb0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.fct.2016.11.029","article-title":"Role for NF-\u03baB inflammatory signalling pathway in tenofovir disoproxil fumarate (TDF) induced renal damage in rats","volume":"99","author":"Ramamoorthy","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.lfs.2017.10.038_bb0095","doi-asserted-by":"crossref","first-page":"936","DOI":"10.2174\/1381612820666140929092929","article-title":"Melatonin and renal protection: novel perspectives from animal experiments and human studies (review)","volume":"21","author":"Hrenak","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.lfs.2017.10.038_bb0100","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/jpi.12362","article-title":"Apoptosis signaling pathways in osteoarthritis and possible protective role of melatonin","volume":"61","author":"Hosseinzadeh","year":"2016","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2017.10.038_bb0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/jpi.12302","article-title":"Melatonin: the dawning of a treatment for fibrosis?","volume":"60","author":"Hu","year":"2016","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2017.10.038_bb0110","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/jpi.12319","article-title":"Melatonin enhances mitophagy and mitochondrial biogenesis in rats with carbon tetrachloride-induced liver fibrosis","volume":"60","author":"Kang","year":"2016","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2017.10.038_bb0115","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1089\/end.2009.0035","article-title":"Melatonin attenuates unilateral ureteral obstruction-induced renal injury by reducing oxidative stress, iNOS, MAPK, and NF-kB expression","volume":"23","author":"Ozbek","year":"2009","journal-title":"J. Endourol."},{"key":"10.1016\/j.lfs.2017.10.038_bb0120","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/jpi.12263","article-title":"Melatonin as a preventive and curative therapy against pulmonary hypertension","volume":"59","author":"Maarman","year":"2015","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2017.10.038_bb0125","first-page":"225","article-title":"Melatonin protects kidney against apoptosis induced by acute unilateral ureteral obstruction in rats","volume":"69","author":"Yildirim","year":"2016","journal-title":"Cent. Eur. J Urol."},{"key":"10.1016\/j.lfs.2017.10.038_bb0130","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/jpi.12357","article-title":"The cardioprotective effect of melatonin and exendin-4 treatment in a rat model of cardiorenal syndrome","volume":"61","author":"Chua","year":"2016","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2017.10.038_bb0135","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ejim.2008.12.018","article-title":"Clinical approach to lupus nephritis: recent advances","volume":"20","author":"Molino","year":"2009","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.lfs.2017.10.038_bb0140","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/art.39818","article-title":"Tofacitinib ameliorates murine lupus and its associated vascular dysfunction","volume":"69","author":"Furumoto","year":"2017","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.lfs.2017.10.038_bb0145","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"65","author":"Weening","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2017.10.038_bb0150","article-title":"Effects of N-acetyl-seryl-asparyl-lysyl-proline on blood pressure, renal damage, and mortality in systemic lupus erythematosus","volume":"5","author":"Nakagawa","year":"2017","journal-title":"Phys. Rep."},{"key":"10.1016\/j.lfs.2017.10.038_bb0155","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/iep.12217","article-title":"Role of parnaparin in atherosclerosis","volume":"97","author":"Bonomini","year":"2016","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.lfs.2017.10.038_bb0160","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.HYP.0000153308.91043.97","article-title":"Effect of treatment with candesartan or enalapril on subcutaneous small artery structure in hypertensive patients with noninsulin-dependent diabetes mellitus","volume":"45","author":"Rizzoni","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2017.10.038_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111141","article-title":"Mitochondrial and metabolic dysfunction in renal convoluted tubules of obese mice: protective role of melatonin","volume":"9","author":"Stacchiotti","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2017.10.038_bb0170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/hr.2016.103","article-title":"Effect of long-term treatment with melatonin on vascular markers of oxidative stress\/inflammation and on the anticontractile activity of perivascular fat in aging mice","volume":"40","author":"Agabiti-Rosei","year":"2017","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.lfs.2017.10.038_bb0175","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1002\/tox.22370","article-title":"Acute mercury exposition of virgin, pregnant, and lactating rats: histopathological kidney and liver evaluations","volume":"32","author":"Oliveira","year":"2017","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.lfs.2017.10.038_bb0180","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.nutres.2015.07.001","article-title":"Melatonin reduces obesity and restores adipokine patterns and metabolism in obese (ob\/ob) mice","volume":"35","author":"Favero","year":"2015","journal-title":"Nutr. Res."},{"key":"10.1016\/j.lfs.2017.10.038_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148115","article-title":"Hepatic macrosteatosis is partially converted to microsteatosis by melatonin supplementation in ob\/ob mice non-alcoholic fatty liver disease","volume":"11","author":"Stacchiotti","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2017.10.038_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164423","article-title":"Pristane-accelerated autoimmune disease in (SWR X NZB) F1 mice leads to prominent tubulointerstitial inflammation and human lupus nephritis-like fibrosis","volume":"11","author":"Gardet","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2017.10.038_bb0195","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/0961203309358187","article-title":"Review: lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions","volume":"19","author":"Ortega","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.lfs.2017.10.038_bb0200","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/ar2450","article-title":"The renal metallothionein expression profile is altered in human lupus nephritis","volume":"10","author":"Faurschou","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.lfs.2017.10.038_bb0205","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.trre.2011.10.002","article-title":"Proteinuria: detection and role in native renal disease progression","volume":"26","author":"Gorriz","year":"2012","journal-title":"Transplant. Rev. (Orlando)."},{"key":"10.1016\/j.lfs.2017.10.038_bb0210","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/acr.20441","article-title":"Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring","volume":"63","author":"Hsieh","year":"2011","journal-title":"Arthritis Care Res. (Hoboken)."},{"key":"10.1016\/j.lfs.2017.10.038_bb0215","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ki.2010.13","article-title":"Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system","volume":"77","author":"Yu","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2017.10.038_bb0220","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/0961203309346906","article-title":"Oxidative stress and homocysteine metabolism in patients with lupus nephritis","volume":"19","author":"Moroni","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.lfs.2017.10.038_bb0225","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1097\/01.ASN.0000033611.79556.AE","article-title":"TGF-beta signaling in renal disease","volume":"13","author":"B\u00f6ttinger","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.lfs.2017.10.038_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/613136","article-title":"Effects of pristane alone or combined with chloroquine on macrophage activation, oxidative stress, and Th1\/Th2 skewness","volume":"2014","author":"Ouyang","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.lfs.2017.10.038_bb0235","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jaut.2015.01.008","article-title":"Anti-dsDNA antibody induces soluble fibronectin secretion by proximal renal tubular epithelial cells and downstream increase of TGF-\u03b21 and collagen synthesis","volume":"58","author":"Yung","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.lfs.2017.10.038_bb0240","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jphs.2017.02.015","article-title":"Effects of a spleen tyrosine kinase inhibitor on progression of the lupus nephritis in mice","volume":"134","author":"Kitai","year":"2017","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2017.10.038_bb0245","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3389\/fimmu.2017.00405","article-title":"Interleukin-6 signaling pathway and its role in kidney disease: an update","volume":"8","author":"Su","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2017.10.038_bb0250","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ki.2013.343","article-title":"Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-\u03baB-mediated inflammatory response","volume":"85","author":"Jiang","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2017.10.038_bb0255","first-page":"2013","article-title":"Mediators of inflammation and their effect on resident renal cells: implications in lupus nephritis","volume":"317682","author":"Yung","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.lfs.2017.10.038_bb0260","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0002-9343(00)00311-9","article-title":"Apoptotic mechanisms in acute renal failure","volume":"108","author":"Ueda","year":"2000","journal-title":"Am. J. Med."},{"key":"10.1016\/j.lfs.2017.10.038_bb0265","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/1440-1681.12576","article-title":"miR-410 suppresses the expression of interleukin-6 as well as renal fibrosis in the pathogenesis of lupus nephritis","volume":"43","author":"Liu","year":"2016","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.lfs.2017.10.038_bb0270","doi-asserted-by":"crossref","first-page":"20309","DOI":"10.1074\/jbc.M202634200","article-title":"Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells","volume":"277","author":"Yamagishi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2017.10.038_bb0275","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5301\/JN.2011.8451","article-title":"Increased apoptosis and expression of FasL, Bax and caspase-3 in human lupus nephritis class II and IV","volume":"25","author":"Cui","year":"2012","journal-title":"J. Nephrol."},{"key":"10.1016\/j.lfs.2017.10.038_bb0280","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/jpi.12360","article-title":"Melatonin as an antioxidant: under promises but over delivers","volume":"61","author":"Reiter","year":"2016","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2017.10.038_bb0285","first-page":"2010","article-title":"Regulatory effect of melatonin on cytokine disturbances in the pristane-induced lupus mice","author":"Zhou","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.lfs.2017.10.038_bb0290","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0079-6123(08)81008-4","article-title":"Melatonin: a multitasking molecule","volume":"181","author":"Reiter","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.lfs.2017.10.038_bb0295","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1517\/14728222.2013.834890","article-title":"Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review","volume":"17","author":"Bizzarri","year":"2013","journal-title":"Expert Opin. Ther. Targets"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320517305544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320517305544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:48:35Z","timestamp":1788886115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320517305544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":59,"alternative-id":["S0024320517305544"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2017.10.038","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral supplementation of melatonin protects against lupus nephritis renal injury in a pristane-induced lupus mouse model","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2017.10.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}